Havah Therapeutics today, announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (US Patent No. 12,128,055) for its innovative T+Ai combination therapy—a novel ...
ConnexPay’s patent, U.S. Patent No. 12,118,519 granted by the United States Patent and Trademark Office, is titled ...
Samsung has already filed a patent for the upcoming foldable phone with the United States Patent and Trademark Office (USPTO) ...
Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...
Although the company remains quiet about the project, this patent—filed with the United States Patent and Trademark Office (USPTO)—gives some clues as to Samsung’s vision for this next-generation ...
BluSmart, South Asia's premier EV ride-hailing service and EV charging infrastructure network, has reported a 77% ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
On October 17, 2024, Adial announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent. The patent, once issued, will cover additional genotype ...
Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement ...
Havah Therapeutics today, announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (US Patent No. 12,128,055) for its innovative T+Ai combination therapy?a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback